AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
Sep 25, 2015
30583_dirs_2015-09-25_ac129e06-940b-4f96-8b60-96c649515f47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-09-08
Reporting Person: HERON ELAINE J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-08 | Common Stock | M | 15000 | $21.51 | Acquired | 35625 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-08 | Stock Option (right to buy) Common Stock | $21.51 | M | 15000 | Disposed | 2020-05-11 | Common Stock (15000) | Direct |
Footnotes
F1: Stock option grant vests 6/48ths on November 12, 2010, and 1/48th on the 12th day of every month thereafter.
F2: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19